These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1774421)

  • 1. Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants.
    Agosti V; Stewart JW; Quitkin FM
    J Affect Disord; 1991 Sep; 23(1):35-41. PubMed ID: 1774421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment.
    Stewart JW; Quitkin FM; McGrath PJ; Rabkin JG; Markowitz JS; Tricamo E; Klein DF
    Psychiatry Res; 1988 Aug; 25(2):213-22. PubMed ID: 3051072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives.
    Rothschild R; Quitkin HM; Quitkin FM; Stewart JW; Ocepek-Welikson K; McGrath PJ; Tricamo E
    Int J Eat Disord; 1994 Jan; 15(1):1-9. PubMed ID: 8124322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
    Miller IW; Keitner GI; Schatzberg AF; Klein DN; Thase ME; Rush AJ; Markowitz JC; Schlager DS; Kornstein SG; Davis SM; Harrison WM; Keller MB
    J Clin Psychiatry; 1998 Nov; 59(11):608-19. PubMed ID: 9862607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic depression: response to placebo, imipramine, and phenelzine.
    Stewart JW; McGrath PJ; Quitkin FM; Rabkin JG; Harrison W; Wager S; Nunes E; Ocepek-Welikson K; Tricamo E
    J Clin Psychopharmacol; 1993 Dec; 13(6):391-6. PubMed ID: 8120152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of antidepressant trials: clinical and research implications.
    Donovan SJ; Quitkin FM; Stewart JW; Ocepek-Welikson K; Harrison W; McGrath PJ; Nunes EV; Wager S; Tricamo E
    J Clin Psychopharmacol; 1994 Feb; 14(1):64-6. PubMed ID: 8151005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. l-Deprenyl in atypical depressives.
    Quitkin FM; Liebowitz MR; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Markowitz J; Davies SO
    Arch Gen Psychiatry; 1984 Aug; 41(8):777-81. PubMed ID: 6430257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design.
    Quitkin FM; Harrison W; Stewart JW; McGrath PJ; Tricamo E; Ocepek-Welikson K; Rabkin JG; Wager SG; Nunes E; Klein DF
    Arch Gen Psychiatry; 1991 Apr; 48(4):319-23. PubMed ID: 2009033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression.
    McGrath PJ; Stewart JW; Nunes EV; Ocepek-Welikson K; Rabkin JG; Quitkin FM; Klein DF
    Am J Psychiatry; 1993 Jan; 150(1):118-23. PubMed ID: 8417553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis.
    Goldberg JF; Harrow M
    J Affect Disord; 2005 Dec; 89(1-3):79-89. PubMed ID: 16249035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo.
    Kocsis JH; Schatzberg A; Rush AJ; Klein DN; Howland R; Gniwesch L; Davis SM; Harrison W
    Arch Gen Psychiatry; 2002 Aug; 59(8):723-8. PubMed ID: 12150648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenelzine for chronic depression: a study of continuation treatment.
    Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
    J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Wager SG; Nunes E; Rabkin JG; Tricamo E; Markowitz J; Klein DF
    Arch Gen Psychiatry; 1989 Sep; 46(9):787-93. PubMed ID: 2673130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of antidepressant treatment outcome in melancholia: psychosocial, clinical and biological indicators.
    Vallejo J; Gasto C; Catalan R; Bulbena A; Menchon JM
    J Affect Disord; 1991 Mar; 21(3):151-62. PubMed ID: 1829739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Tricamo E; Wager SG; Ocepek-Welikson K; Nunes E; Rabkin JG; Klein DF
    Arch Gen Psychiatry; 1990 Oct; 47(10):935-41. PubMed ID: 2222132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients.
    Bodkin JA; Amsterdam JD
    Am J Psychiatry; 2002 Nov; 159(11):1869-75. PubMed ID: 12411221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes.
    Kocsis JH; Zisook S; Davidson J; Shelton R; Yonkers K; Hellerstein DJ; Rosenbaum J; Halbreich U
    Am J Psychiatry; 1997 Mar; 154(3):390-5. PubMed ID: 9054788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of phenelzine in continuation therapy.
    Davidson J; Raft D
    Neuropsychobiology; 1984; 11(3):191-4. PubMed ID: 6433222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How symptomatic do depressed patients remain after benefiting from medication treatment?
    Agosti V; Stewart JW; Quitkin FM; Ocepek-Welikson K
    Compr Psychiatry; 1993; 34(3):182-6. PubMed ID: 8339536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.